Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The ...

Researchers have shown, for the first time, how the genetic material of the Nipah virus replicates in infected cells. The ...

To maintain vaccine efficacy, WHO regularly updates influenza vaccine strains based on global epidemiological, virological, ...

COVID-19 affects hundreds of millions of people worldwide and is often associated with long-term neurological abnormalities.

The replication of the Nipah virus's genetic material in infected cells has been demonstrated for the first time by ...

reveals extensive interactions between portions of the viral RNA genome and the icosahedral capsid. Under the protein shell of the T = 3 quasi equivalent capsid lies a dodecahedral cage composed ...

As viral vaccines are increasingly used to meet global health needs, the pharmaceutical industry is manufacturing larger ...

ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...

This page is no longer being updated and reflects the status of vaccine progress through March 4, 2021. For more coverage about the pandemic, visit our coronavirus hub. 3 vaccineshave been ...

Merck's DOR/ISL met primary efficacy and safety goals in two Phase 3 HIV trials. Marketing applications are planned for ...

Results show similar levels of virus undetectability in patients on ibalizumab-containing regimens as in controls, despite greater baseline ...